{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:15Z","timestamp":1786987395058,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.coph.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T00:33:54Z","timestamp":1360370034000},"page":"301-308","source":"Crossref","is-referenced-by-count":15,"title":["Calcium antagonists in the treatment of coronary artery disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Rhonda M","family":"Cooper-DeHoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2013.01.008_bib0005","article-title":"2010 top 200 generic drugs by total prescription","year":"2011","journal-title":"Drug Top"},{"key":"10.1016\/j.coph.2013.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0020","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease, The International Verapamil\u2013Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2013.01.008_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2004.057703","article-title":"Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS)","volume":"92","author":"Hjemdahl","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.coph.2013.01.008_bib0035","first-page":"81","article-title":"The importance of energy-rich phosphate for contractility and tonus of the myocardium","volume":"70","author":"Fleckenstein","year":"1964","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"10.1016\/j.coph.2013.01.008_bib0040","first-page":"I3","article-title":"History of calcium antagonists","volume":"52","author":"Fleckenstein","year":"1983","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2013.01.008_bib0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_sbref0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11906-012-0269-4","article-title":"Pleiotropic effects of calcium channel blockers","volume":"14","author":"Preston Mason","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.coph.2013.01.008_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.37.1.34","article-title":"Synergistic antihypertensive effects of nifedipine on endothelium: concurrent release of NO and scavenging of superoxide","volume":"37","author":"Brovkovych","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2013.01.008_bib0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","article-title":"Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent","volume":"97","author":"Zhang","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.0000046488.52939.BF","article-title":"Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function)","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/eurheartj\/ehp151","article-title":"A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study","volume":"30","author":"Luscher","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0285","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_sbref0085","series-title":"National Institute for Health and Clinical Excellence 2011 Management of Stable Angina (CG126)","year":"2011"},{"key":"10.1016\/j.coph.2013.01.008_bib0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0105","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2013.01.008_bib0110","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2013.01.008_bib0115","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2013.01.008_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1291\/hypres.27.181","article-title":"Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial","volume":"27","author":"Yui","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.coph.2013.01.008_bib0125","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2013.01.008_bib0130","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2013.01.008_bib0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.eurheartj.a014668","article-title":"Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group","volume":"17","author":"Dargie","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2004.01.006","article-title":"Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects","volume":"93","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2013.01.008_bib0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","article-title":"Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR\u2013Trandolapril STudy [INVEST])","volume":"98","author":"Cooper-Dehoff","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2013.01.008_bib0155","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2337\/dc07-1768","article-title":"Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the relative influence of antihypertensive medication","volume":"31","author":"Gupta","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.coph.2013.01.008_bib0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2125.2011.04002.x","article-title":"How to manage hypertension in pregnancy effectively","volume":"72","author":"Magee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2013.01.008_bib0165","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0170","series-title":"National Institute for Health and Clinical Excellence 2011 Hypertension in pregnancy (CG107)","year":"2010"},{"key":"10.1016\/j.coph.2013.01.008_bib0175","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2013.01.008_bib0180","author":"Gibbons","year":"2002"},{"key":"10.1016\/j.coph.2013.01.008_bib0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2008.09.043","article-title":"Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis","volume":"122","author":"Bangalore","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.coph.2013.01.008_bib0190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-8703(97)70150-9","article-title":"Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction","volume":"133","author":"Kostis","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0200","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_sbref0205","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0210","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9149(90)90351-Z","article-title":"Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II\u2014DAVIT II)","volume":"66","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2013.01.008_bib0215","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9149(93)91069-T","article-title":"Are all calcium antagonists equally effective for reducing reinfarction rate?","volume":"72","author":"Messerli","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2013.01.008_bib0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9149(97)89365-4","article-title":"A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS)","volume":"77","author":"Rengo","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2013.01.008_sbref0225","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1253\/circj.CJ-10-1078","article-title":"Secondary preventive effects of a calcium antagonist for ischemic heart attack: randomized parallel comparison with beta-blockers","volume":"75","author":"Nakagomi","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.coph.2013.01.008_bib0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 2","key":"10.1016\/j.coph.2013.01.008_bib0235","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2013.01.008_bib0240","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s001250050023","article-title":"Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes","volume":"43","author":"Lehto","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2013.01.008_bib0245","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/diacare.23.8.1097","article-title":"Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study","volume":"23","author":"Pyorala","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.coph.2013.01.008_bib0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ajh\/5.10.775","article-title":"Antihypertensive drug therapy and insulin resistance","volume":"5","author":"Prisant","year":"1992","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.coph.2013.01.008_bib0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-122-2-199501150-00010","article-title":"Effects of antihypertensive therapy on serum lipids","volume":"122","author":"Kasiske","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coph.2013.01.008_bib0260","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/eurheartj\/ehl403","article-title":"Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"27","author":"Sever","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2013.01.008_bib0265","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1524-6175.2006.05690.x","article-title":"A randomized, double-blind trial comparing the effects of amlodipine besylate\/benazepril HCl vs amlodipine on endothelial function and blood pressure","volume":"8","author":"Mohler","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.coph.2013.01.008_bib0270","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.CIR.103.6.799","article-title":"Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase","volume":"103","author":"Hornig","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2013.01.008_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0895-7061(02)03154-0","article-title":"Effect of AT1 receptor blockade on endothelial function in essential hypertension","volume":"16","author":"Klingbeil","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.coph.2013.01.008_bib0280","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921300012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921300012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T17:29:46Z","timestamp":1539883786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148921300012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S147148921300012X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2013.01.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}